U.S. Healthtech Stock News

Suburban Propane Partners (SPH) has drawn fresh attention after reporting second quarter fiscal 2026 earnings, with net income holding near last year despite lower revenue and continued progress in renewable natural gas projects. See our latest analysis for Suburban Propane Partners. Suburban Propane Partners’ share price has been relatively steady over recent months. The current price of $19.61 sits alongside a year to date share price return of 4.92%, while longer term total shareholder...

D-Market Elektronik Hizmetler ve Ticaret (HEPS) is back on investors’ radar after reporting first quarter 2026 results, with higher sales and gross merchandise value alongside a wider net loss driven by growth investments. See our latest analysis for D-Market Elektronik Hizmetler ve Ticaret. The earnings release appears to have cooled very short term sentiment, with the share price down 2.48% over the last day and 1.43% over the week. However, a 7.42% year to date share price return contrasts...

What Bruker’s recent performance means for investors Bruker (BRKR) has drawn attention after a mixed stretch for the stock, with a gain of about 19% over the past week and an increase of roughly 15% over the past month. See our latest analysis for Bruker. That recent burst of momentum, with an 18.9% 7 day share price return and a 15.1% 30 day share price return to US$43.27, contrasts with a softer year to date share price return and a 3 year total shareholder return that has been weak. As a...

DraftKings (DKNG) drew fresh attention after reporting first quarter 2026 results that combined higher sales, a move into profitability, and a larger push into prediction markets, which is setting up new questions for investors. See our latest analysis for DraftKings. The earnings surprise has come against a mixed share price backdrop, with the stock at US$24.51 after a 1 month share price return of 10.26%, yet a year to date share price return that is down 31.27% and a 1 year total...

Why Westlake Stock Is Drawing Attention Now Westlake (WLK) is back on investors’ radar after recent share price swings, with the stock up about 4% over the past day but down roughly 18% over the past month. See our latest analysis for Westlake. The recent 1-day share price return of 3.95% comes after a tougher stretch, with the 30-day share price return down 17.58% even as the year-to-date share price return is 31.57% and the 1-year total shareholder return is 16.98%. This points to fading...

KB Home (KBH) stock is in focus after its latest quarterly update showed revenue down 22.6% year on year and below analyst expectations, which has weighed on sentiment, even though management pointed to a larger community count next quarter. See our latest analysis for KB Home. The weaker quarter and recent executive changes have coincided with softer momentum. The share price is at $47.87 after falling 24.63% over 90 days, while the 5 year total shareholder return of 12.92% points to a more...

In early May 2026, Las Vegas Sands Corp. completed two fixed-rate, callable senior unsecured note offerings totaling about US$998.30 million, with coupons of 5.30% due 2031 and 5.65% due 2033, alongside additions of BNP Paribas, Scotia Capital and Morgan Stanley as co-lead underwriters. While these bond issues refine Las Vegas Sands' funding mix, investor attention remains heavily influenced by ongoing Macau revenue pressures and related sentiment. Next, we'll examine how these new...

In early May 2026, OneMain Holdings reported first-quarter 2026 net income of US$226 million versus US$213 million a year earlier, completed a buyback of 2,308,900 shares for US$141.58 million, and affirmed a quarterly dividend of US$1.05 per share payable on May 15, 2026. Together, the higher quarterly net income, completed repurchase of nearly 2% of shares, and continued cash dividend underline the company’s focus on returning capital while maintaining earnings strength. We’ll now examine...

NRSInsights data on April same-store sales and transaction values has put a spotlight on IDT (IDT), as investors weigh how this retail activity feeds into the company’s broader communications and fintech operations. See our latest analysis for IDT. At a share price of $52.16, IDT has a 30 day share price return of 5.01% and a 90 day share price return of 6.38%, while the 1 year total shareholder return is down 9.36% and the 5 year total shareholder return is up 103.87%. This indicates that...

In May 2026, Terex Corporation reported first-quarter 2026 results showing sales of US$1,734 million, up from US$1,229 million a year earlier, but a net loss of US$89 million versus prior net income of US$21 million, alongside no share repurchases under its July 2025 authorization and completion of a US$117.16 million buyback launched in December 2022. This combination of stronger revenues with a shift to loss-making operations, plus a pause on the newer repurchase plan, raises fresh...

H&R Block (HRB) has jumped back into focus after third quarter earnings, with higher revenue and net income supported by a tax benefit and buybacks, a raised 2026 outlook, and ongoing dividend support. See our latest analysis for H&R Block. The strong third quarter update, outlook upgrade and dividend affirmation have come after a weaker start to the year, with the share price still down about 15% year to date despite a 21% 30 day share price gain and a much stronger 3 and 5 year total...

Casey's General Stores (CASY) is pushing deeper into the US South with new stores in Alabama and Florida, including converted former CEFCO locations, putting its pizza focused convenience model up against established regional chains. See our latest analysis for Casey's General Stores. These southern store openings come as investor enthusiasm is already strong, with the share price at US$877.07 and a 30 day share price return of 18.82% contributing to a 1 year total shareholder return of...

Fluor (FLR) just released first quarter 2026 results that fell short of analyst expectations, after higher project costs and geopolitical delays pressured earnings and led management to narrow its full year adjusted EBITDA guidance. See our latest analysis for Fluor. The stock reacted sharply to the earnings miss and tightened guidance, with a 7 day share price return that declined 16.77% and a 30 day share price return that declined 11.22%, although the 1 year total shareholder return of...

Oruka Therapeutics (ORKA) stock is drawing attention after a recently completed $700 million common stock offering raised dilution concerns and coincided with volatility around its Halozyme Hypercon collaboration and interim clinical trial updates. See our latest analysis for Oruka Therapeutics. At a latest share price of US$65.68, Oruka’s recent common stock offering, Halozyme Hypercon agreement and interim trial readouts have gone hand in hand with sharp swings, including a 99.76% 3 month...

OneSpaWorld Holdings (OSW) has drawn fresh attention after reporting first quarter earnings, with revenue of US$247.63 million and net income of US$21.33 million, and raising full year revenue guidance. See our latest analysis for OneSpaWorld Holdings. The 1-year total shareholder return of 24.31% and 3-year total shareholder return of 105.87% point to strong long term wealth creation. Meanwhile, the year to date share price return of 16.23% suggests momentum has been building despite a...

Baidu’s chip unit IPO plans put Kunlunxin in the spotlight Baidu (NasdaqGS:BIDU) is moving ahead with an IPO for its Kunlunxin chip subsidiary on Shanghai’s STAR Board, while also preparing for a potential Hong Kong listing. This could reshape how investors view its AI chip operations. See our latest analysis for Baidu. The Kunlunxin IPO plans land at a time when Baidu’s short term momentum is strong, with a 34.47% 1 month share price return and a 59.72% 1 year total shareholder return,...

Inhibrx Biosciences recently reported positive interim Phase 2 data from the HexAgon study, where its hexavalent OX40 agonist INBRX-106 combined with pembrolizumab produced higher confirmed response rates and more complete responses than pembrolizumab alone in first-line PD-L1 high head and neck cancer patients. These data, supported by strong T-cell activation signals and a generally manageable safety profile, have prompted plans for a Phase 3 trial and broader exploration of INBRX-106...

Universal Technical Institute, Inc. reported past second‑quarter 2026 results with revenue rising to US$221.4 million from US$207.45 million a year earlier, while net income fell to US$0.433 million from US$11.45 million as higher operating and growth-related costs compressed earnings per share from US$0.21 to US$0.01. Management framed this profit squeeze as the result of heavy spending on new campuses and programs, reaffirming full‑year guidance and underscoring a willingness to accept...

Li Auto (LI) is back in focus after its stock gained more than 4% in pre market trading, with investors reacting to growing interest in the upcoming Li Auto L9 Livis launch. See our latest analysis for Li Auto. Beyond the pre market jump, Li Auto’s 1 day share price return of 4.83% and 7 day share price return of 5.54% come after a year to date share price gain of 9.39%. However, the 1 year total shareholder return is down 33.51% and longer term total shareholder returns also remain weak,...

In early May 2026, Corvus Pharmaceuticals reported a first-quarter 2026 net loss of US$13.69 million, reversing from net income a year earlier, while also filing a US$46.16 million shelf registration for nearly 2,987,865 shares related to its employee stock ownership plan. At the same time, the company highlighted positive clinical progress for its lead ITK inhibitor soquelitinib across multiple immune and oncology indications, supported by a cash position that management expects will fund...

Why Veeco’s new Indium Phosphide orders matter for investors Veeco Instruments (VECO) has drawn fresh attention after announcing more than US$250 million in new equipment orders tied to Indium Phosphide laser production for high speed optical transceivers in hyperscale data centers. For you as an investor, the interest here is less about a single headline number and more about what it signals: that Veeco’s tools sit directly in the supply chain for the shift from copper to optical...

Hess Midstream (HESM) reported first quarter 2026 results that showed higher revenue and net income versus the prior year, while also reaffirming full year earnings and operating guidance, a combination many income focused investors watch closely. See our latest analysis for Hess Midstream. Hess Midstream’s recent earnings announcement comes after a steady share price move, with the stock up 13.10% on a year to date share price basis and a 5 year total shareholder return of 140.87%. This...

Earlier in May 2026, Booking Holdings issued multiple fixed-rate senior unsecured notes in US$ and euros, while also reporting first‑quarter 2026 revenue of US$5,532 million and net income of US$1,083 million. Despite these strong quarterly figures, management reduced full‑year 2026 guidance due to Middle East conflict risks, macro pressures, and rising competition, highlighting how geopolitical shocks can weigh on a global travel platform even when recent performance looks strong. Next,...

In early May 2026, Diamondback Energy raised its 2026 production guidance, reported higher year-on-year first-quarter volumes, booked US$1.40 billion in property impairments, and still lifted its base quarterly dividend to US$1.10 per share while continuing share repurchases. The combination of higher expected oil output, significant non‑cash impairments weighing on earnings, and ongoing cash returns to shareholders highlights a complex trade‑off between growth investment, balance sheet...